Consultant

Portfolio development (RX/OTC). Reported to CEO, 5 subordinates Responsibilities * development and introduction of the new products (from decision to product in stock) ; * introduction of changes of the current products Main duties * selection of promising products and their sources ; * development of the technical specification (new product/ changes), financial model (P&L) and action plan ; * project team management (marketing, medical, financial, legal, registration, compliance, logistics etc. departments and third parties) ; * preparation and conduct of due diligence (in-licensing transactions) ; * support for localization projects

New products development management. Reported to R&D deputy director, 2 subordinates. Responsibilities * development and introduction of the new products (from decision to product in stock) ; * introduction of changes of the current products Main duties * selection of promising products and their sources ; * development of the technical specification (new product/ changes), financial model (P&L) and action plan ; * project team management (marketing, medical, financial, legal, registration, compliance, logistics etc. departments and third parties) ; * preparation and conduct of due diligence (in-licensing transactions)

I worked for the Russian pharmaceutical company «Valenta» (form. "Otechestvennye lekarstva"), starting from the position of product manager and finishing as a strategic development manager in the marketing department. My work represented classical product management in pharma (market analysis, development and implementation of marketing plan, development and implementation of creative strategies in cooperation with advertising agencies, development of advertising materials, training of medical representatives, relations with opinion leaders, development and implementation of a clinical research plan etc.). Since 2006 - in the role of lead. The main focus of my work was the original drug Fentropil, which for the years of my work took a share of 15% in the nootropic segment ($ 25 million) from scratch:

Medical support for Marketing Dept. Development and launch of a new product (ARTRA®), product-management of Calcium line products (Vitrum® Calcium D3, Vitrum® Osteomag).